Visceral Fat
Also known as Visceral Adipose Tissue · VAT
Fat stored around internal organs — metabolically active, tied to cardiovascular risk, and the target of Tesamorelin and SCULPT.
Definition
Visceral adipose tissue is the fat surrounding the liver, pancreas and intestines inside the abdominal cavity — distinct from the subcutaneous fat under the skin. It secretes inflammatory cytokines and free fatty acids directly into the portal circulation, which is why elevated visceral fat drives metabolic syndrome and cardiovascular risk out of proportion to BMI. Tesamorelin has the strongest clinical evidence for reducing it.
Read More
Tesamorelin
A stabilised GHRH analog with FDA approval for visceral-fat reduction in HIV-associated lipodystrophy — increasingly used off-label for metabolic syndrome.
Clinical ConceptMetabolic Syndrome
A cluster of five conditions — central obesity, hypertension, dyslipidaemia, hyperglycaemia, low HDL — that together multiply cardiovascular risk.
MechanismLipolysis
The biological breakdown of stored fat into free fatty acids — the mechanism targeted by AOD-9604 and Tesamorelin.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.